82 related articles for article (PubMed ID: 19684380)
1. New methodological approach for the rapid and sensitive detection of melanocytes and melanocytic tumours. The DOPA-GA method.
Ichikawa A; Takagi H; Suda K; Yao T
Dermatology; 2009; 219(3):195-201. PubMed ID: 19684380
[TBL] [Abstract][Full Text] [Related]
2. Formation of melanin-tyrosinase complex and its possible significance as a model for control of melanin synthesis.
Menon IA; Haberman HF
Acta Derm Venereol; 1978; 58(1):9-11. PubMed ID: 75646
[TBL] [Abstract][Full Text] [Related]
3. [Immunohistochemical demonstration of tyrosinase 4 in normal skin and melanocytic tumors].
Kageshita T; Ono T; Arao T; Tomita Y
Nihon Hifuka Gakkai Zasshi; 1987 May; 97(6):685-90. PubMed ID: 3114516
[No Abstract] [Full Text] [Related]
4. Cyclooxygenase-2 (COX-2): first immunohistochemical marker distinguishing early cutaneous melanomas from benign melanocytic skin tumours.
Chwirot BW; Kuźbicki Ł
Melanoma Res; 2007 Jun; 17(3):139-45. PubMed ID: 17505259
[TBL] [Abstract][Full Text] [Related]
5. T311--an anti-tyrosinase monoclonal antibody for the detection of melanocytic lesions in paraffin embedded tissues.
Jungbluth AA; Iversen K; Coplan K; Kolb D; Stockert E; Chen YT; Old LJ; Busam K
Pathol Res Pract; 2000; 196(4):235-42. PubMed ID: 10782467
[TBL] [Abstract][Full Text] [Related]
6. Effect of Angelica sinensis (Oliv.) on melanocytic proliferation, melanin synthesis and tyrosinase activity in vitro.
Deng Y; Yang L
Di Yi Jun Yi Da Xue Xue Bao; 2003 Mar; 23(3):239-41. PubMed ID: 12651240
[TBL] [Abstract][Full Text] [Related]
7. Distinguishing benign and malignant melanocytic lesions with the AgNOR method.
Friedman RJ; Grin CM; Heilman E; Weiser J; Gottlieb GJ; Waldo E; Rigel DS; Kopf AW
Dermatol Clin; 1991 Oct; 9(4):689-93. PubMed ID: 1934643
[TBL] [Abstract][Full Text] [Related]
8. Sensitivity and specificity of histological criteria in the diagnosis of conventional cutaneous melanoma.
Urso C; Saieva C; Borgognoni L; Tinacci G; Zini E
Melanoma Res; 2008 Aug; 18(4):253-8. PubMed ID: 18626309
[TBL] [Abstract][Full Text] [Related]
9. Detection of tyrosinase mRNA from the blood of melanoma patients.
Stevens GL; Scheer WD; Levine EA
Cancer Epidemiol Biomarkers Prev; 1996 Apr; 5(4):293-6. PubMed ID: 8722221
[TBL] [Abstract][Full Text] [Related]
10. Detection of tyrosinase mRNA by an optimised nested RT-PCR in the peripheral blood of patients with advanced malignant melanoma.
Glumac N; Hocevar M; Snoj M; Novakovic S
J Exp Clin Cancer Res; 2001 Dec; 20(4):529-36. PubMed ID: 11876547
[TBL] [Abstract][Full Text] [Related]
11. The stepwise two-photon excited melanin fluorescence is a unique diagnostic tool for the detection of malignant transformation in melanocytes.
Leupold D; Scholz M; Stankovic G; Reda J; Buder S; Eichhorn R; Wessler G; Stücker M; Hoffmann K; Bauer J; Garbe C
Pigment Cell Melanoma Res; 2011 Jun; 24(3):438-45. PubMed ID: 21457482
[TBL] [Abstract][Full Text] [Related]
12. Common acquired melanocytic nevi, melanocytic dysplasia and malignant melanoma. A morphometric study.
Santucci M; Urso C; Giannini A; Bondi R
Appl Pathol; 1989; 7(2):111-5. PubMed ID: 2730799
[TBL] [Abstract][Full Text] [Related]
13. Optimization of the tyrosinase mRNA probe to detect circulating melanocytes with reverse transcription and polymerase chain reaction.
Carrillo E; Marchal JA; Prados J; Melguizo C; Vélez C; Arena N; Alvarez L; Serrano S; Aránega A
Cell Mol Biol (Noisy-le-grand); 1998 Dec; 44(8):1247-52. PubMed ID: 9874512
[TBL] [Abstract][Full Text] [Related]
14. Dopa oxidase activity in the hair, skin and ocular melanocytes is increased in the presence of stressed fibroblasts.
Balafa C; Smith-Thomas L; Phillips J; Moustafa M; George E; Blount M; Nicol S; Westgate G; MacNeil S
Exp Dermatol; 2005 May; 14(5):363-72. PubMed ID: 15854130
[TBL] [Abstract][Full Text] [Related]
15. Novel tyramide-based tyrosinase assay for the detection of melanoma cells in cytological preparations.
Angeletti C; Khomitch V; Halaban R; Rimm DL
Diagn Cytopathol; 2004 Jul; 31(1):33-7. PubMed ID: 15236262
[TBL] [Abstract][Full Text] [Related]
16. Co-regulation of melanin precursors and tyrosinase in human pigment cells: roles of cysteine and glutathione.
Benathan M; Virador V; Furumura M; Kobayashi N; Panizzon RG; Hearing VJ
Cell Mol Biol (Noisy-le-grand); 1999 Nov; 45(7):981-90. PubMed ID: 10644002
[TBL] [Abstract][Full Text] [Related]
17. Tyrosinase-related proteins suppress tyrosinase-mediated cell death of melanocytes and melanoma cells.
Rad HH; Yamashita T; Jin HY; Hirosaki K; Wakamatsu K; Ito S; Jimbow K
Exp Cell Res; 2004 Aug; 298(2):317-28. PubMed ID: 15265682
[TBL] [Abstract][Full Text] [Related]
18. [Hominis placenta promotes melanocyte proliferation melanin synthesis and tyrosinase activity in vitro].
Yang L; Deng Y
Di Yi Jun Yi Da Xue Xue Bao; 2004 Sep; 24(9):1040-1, 1044. PubMed ID: 15447857
[TBL] [Abstract][Full Text] [Related]
19. Tyrosinase activity in serum from patients with malignant melanoma.
Agrup P; Carstam R; Wittbjer A; Rorsman H; Rosengren E
Acta Derm Venereol; 1989; 69(2):120-4. PubMed ID: 2564228
[TBL] [Abstract][Full Text] [Related]
20. Sensitivity, specificity, and diagnostic accuracy of three dermoscopic algorithmic methods in the diagnosis of doubtful melanocytic lesions: the importance of light brown structureless areas in differentiating atypical melanocytic nevi from thin melanomas.
Annessi G; Bono R; Sampogna F; Faraggiana T; Abeni D
J Am Acad Dermatol; 2007 May; 56(5):759-67. PubMed ID: 17316894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
